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in cirrhosis?To the Editor:
I read with interest the excellent clinical study by
Gonzalez-Navajas and colleagues [1]. Following their
previous study showing that about 40% of patients
with advanced cirrhosis had bacterial DNA in blood
and ascites and indicating that repeated episodes of
bacterial translocation (BT) evidenced by the detection
of same bacterial DNA in consecutive blood samples
are highly suspected in these patients [2]. In this study
the authors investigated whether the presence of bacte-
rial DNA is associated with pro-inﬂammatory cyto-
kine and nitric oxide responses independently of the
endotoxin pathway. Forty-seven (33%) of 141 patients
with cirrhosis and non-infected ascites showed the
simultaneous presence of bacterial DNA in blood
and ascites. Among these 47 patients, the ﬁrst eight
with bacterial DNA from Gram-positive cocci, the
ﬁrst eight with DNA from Gram-negative bacteria,
and the ﬁrst 16 patients without bacterial DNA were
included in the study. Serum endotoxin and lipopoly-
saccharide-binding protein levels (LBP) in patients
with Gram-positive bacterial DNA were similar to
those in patients without bacterial DNA. Regardless
of lower LBP and endotoxin levels in patients with
Gram-positive bacterial DNA compared to those in
patients with Gram-negative bacterial DNA, serum
levels of tumour necrosis factor (TNF)-a and interleu-
kin-6 (IL-6) in patients with Gram-positive bacterial
DNA were signiﬁcantly higher than those in patients
without bacterial DNA and equivalent to patients
with Gram-negative bacterial DNA. The authors con-
cluded that the detection of bacterial DNA allows the
identiﬁcation of BT in patients with advanced cirrho-
sis, which is associated with increased inﬂammatory
responses independently of endotoxin signaling.
The results of this study are consistent with the sug-
gestion by a recent review [3] that Gram-positive bacteria
or their components play an important role in the
inﬂammatory response in patients with cirrhosis because
the expression of Toll-like receptor (TLR)-2, which
responds predominantly to cell wall components ofGram-positive bacteria, has repeatedly been shown to
be upregulated, whereas the expression of TLR-4, a spe-
ciﬁc transducing receptor for endotoxin, is unaltered or
downregulated in cirrhosis. I would like to address three
questions. First, I would like to ask the authors whether
the relationship between the detection of bacteria by
blood culture and the identiﬁcation of bacterial DNA
by polymerase chain reaction has previously been exam-
ined in cirrhotic or other patients. It has been reported
that there were 16.6% false-positive results when DNA
was isolated from healthy volunteers with a commer-
cially available kit [4]. Contamination can originate from
mastermix reagents and the DNA extraction proce-
dure. Second, the values of TNF-a and IL-6 reported
in this study (mean TNF-a: 324.93 lg/mL, mean IL-6:
294.96 lg/mL in patients with bacterial DNA) are
more than 1,000,000-fold higher than those of our
data and the results of a recent study (mean TNF-a:
90.9 pg/mL, mean IL-6: 84.8 pg/mL in patients with
decompensated cirrhosis) [5]. I think there is an error
in the conversion of the units. Third, I would like to
ask the authors whether the diﬀerence (<0.3 EU/mL)
in endotoxin concentrations between the patients with
Gram-negative bacterial DNA and those with Gram-
positive bacterial DNA is clinically relevant. The bio-
logical activity of endotoxin is not only dependent on
endotoxin and LBP concentrations but also inﬂuenced
by soluble CD14 levels, lipoprotein concentrations, the
expression of membrane CD14, TLR-4, MD-2, and
the activity of transcription factors.
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Bacterial DNA translocation in patients with cirrhosis: Reply
To the Editor:
We thank Fujita and colleagues for their comments
and this opportunity to discuss the questions raised
regarding our recent investigation on bacterial DNA
translocation in patients with cirrhosis.
Our main line of research is focused on the study of
bacterial translocation (BT) in patients with decompen-
sated cirrhosis. Approximately, 30% of these patients
show the simultaneous presence of bacterial DNA (bac-
tDNA) in blood and ascitic ﬂuid (AF) [1,2] and a recent
study in an experimental model of CCl4-induced cirrho-
sis with ascites positively correlated this ﬁnding with the
identiﬁcation of bactDNA in mesenteric lymph nodes
[3]. However, and related to the ﬁrst question, we re-
cently conducted a study in which bactDNA detection
and the associated inﬂammatory response was evaluated
in patients with spontaneous bacterial peritonitis (SBP).
In this study, a total series of 22 patients with SBP was
analyzed. All 22 cases showed the presence of bacterial
genomic fragments as revealed by PCR of the 16SrRNA
gene. Identiﬁcations by DNA sequencing analysis in pa-
tients with culture-positive SBP corresponded to those
isolated by microbiological culture in all cases, except
for one patient that showed a Staphylococcus aureus
by sequencing analysis and a Streptococcus pneumoniae
by microbiological culture [4].
Regarding experimental procedures, control experi-
ments are normally run over all DNA extraction Kit
solutions as well as PCR mastermix reagents. Speciﬁcity
experiments are always completed with a 10 pg-spike of
Escherichia coli DNA to determine the presence of
inhibitors in the media. In addition, all solutions and re-
agents are handled in sterile air-ﬂow chambers previ-
ously irradiated with UV light, and sterile plastic
material and ﬁlter tips are used all along the technique
of DNA isolation and ampliﬁcation. Finally, in all
PCR reactions, two negative controls are always run:
one with sterile water instead of sample templates and
one with PCR mastermix alone. We are aware of the
study by Heininger A et al. in which, as pointed out
by Fujita T, 16.6% false-positive results are present
when DNA is isolated from healthy volunteers with a
commercially available kit [5]. DNA isolation kit used
in that study (Puregene Whole Blood Kit, Biozym Diag-
nostics) is not the same as the one we usually handle
(QiAmp Blood Minikit, QIAgen). Also, the set of prim-
ers used to perform PCR reactions are also diﬀerent in
that study. Therefore, it is diﬃcult for us to compare
or discuss on someone else’s reported contamination
rates.
A signiﬁcantly increased cytokine response is pres-
ent in patients with presence of bactDNA [6,7]. De-
spite this increment, values have never reached lg/ml
levels. This is, as suggested, a typing mistake. All
cytokine determinations were measured in pg/mL.
We apologise for this confusion and thank Dr. Fujita
and colleagues for their appreciation. Indeed, in the
previously mentioned study on the inﬂammatory re-
sponse in patients with advanced cirrhosis and ascites,
extended results on several cytokine levels can be fol-
lowed in diﬀerent clinical settings.
Endotoxin is a diﬃcult to measure parameter. LPS
traces can be detected in serum from patients with pres-
ence of Gram-positive microorganisms. We consider
that reported diﬀerences in endotoxin levels simply re-
ﬂect intrinsic characteristics of both subgroups of bacte-
rial species and do not allow discussion about its
biological activity. For this purpose lipopolysaccharide
binding protein (LBP) measurement has been proposed
instead [8]. However, endotoxin, DNA or peptidogly-
can, among others bacterial products, stimulate the in-
nate immune system and induce the liberation of
proinﬂammatory cytokines and nitric oxide, and these
factors indeed have clinical consequences. The detection
of high levels of endotoxin or the above-mentioned bac-
terial products identify a subgroup of patients with evi-
dences of bacterial translocation, and this may aﬀect
prognosis [9].
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